Red White & Bloom Brands Inc Ordinary Shares RWB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RWB is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CAD 0.08
- Day Range
- CAD 0.08–0.08
- 52-Week Range
- CAD 0.03–0.12
- Bid/Ask
- CAD 0.08 / CAD 0.08
- Market Cap
- CAD 35.27 Mil
- Volume/Avg
- 263,773 / 91,138
Key Statistics
- Price/Earnings (Normalized)
- 0.17
- Price/Sales
- 0.43
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Red White & Bloom Brands Inc is a multi-state operator in the United States conducting operations in the legal cannabis industry. The principal activity of the company is the sale of a diverse range of high-quality cannabis-based products delivered through its distribution and retail channels. The company operates twelve licensed adult-use and medical retail dispensaries located in the legal states of Michigan and Florida. The Company operates in four reportable segments, (1) Corporate segment, (2) Distribution segment, (3) Licensing segment, and (4) Retail segment. Key revenue is generated from Distribution segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- —
- Website
- https://www.redwhitebloom.com
Valuation
|
Metric
|
RWB
|
|---|---|
Price/Earnings (Normalized) | 0.17 |
Price/Book Value | — |
Price/Sales | 0.43 |
Price/Cash Flow | — |
Price/Earnings
RWB
Financial Strength
|
Metric
|
RWB
|
|---|---|
Quick Ratio | 0.15 |
Current Ratio | 0.25 |
Interest Coverage | −43.31 |
Quick Ratio
RWB
Profitability
|
Metric
|
RWB
|
|---|---|
Return on Assets (Normalized) | −21.94% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −30.54% |
Return on Assets
RWB
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Lzdgppgjw | Kbvpp | $79.1 Bil | |
MKKGY
| Merck KGaA ADR | Wmrczqrp | Xqgyzh | $74.3 Bil | |
HLN
| Haleon PLC ADR | Lwgvyhyt | Vhh | $38.1 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Szpkddjpy | Wml | $19.1 Bil | |
VTRS
| Viatris Inc | Qwggcvqr | Njbvq | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Mkqmzsmzb | Jkvkw | $11.7 Bil | |
CTLT
| Catalent Inc | Ncprxvrv | Jddhv | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Kprhzpz | Zwnqk | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Mcsbdwcrp | Yljt | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Dyxfgpwsv | Ttgkvn | $3.3 Bil |